InfoMedics Presents Studies Highlighting Adults’ Experiences With ADHD Drug

InfoMedics, Inc., the patient feedback company, recently co-authored two posters detailing patients’ experiences with the attention-deficit/hyperactivity disorder (ADHD) drug lisdexamfetamine dimesylate (LDX). The posters were presented at the American Psychiatric Association (APA) and the College of Psychiatric and Neurologic Pharmacists’ (CPNP) annual meetings.

More: continued here

Filed under: ADHD on June 8th, 2009